Raccoon poxvirus as a mucosal vaccine vector for domestic cats

Journal of Drug Targeting

Volumn 11, Issue 8-10, 2003, Pages 463-470

  Osorio, Jorge E ^a,b   Frank, Rexann S ^a   Moss, Kelley ^a   Taraska, Terri ^a   Powell, Tim ^a   Stinchcomb, Dan T ^a  

^a HESKA CORPORATION   (United States)

^b PowderJect Vaccines   (United States)

Author keywords

Cats; Mucosal vaccination; Rabies; Raccoon poxvirus

Indexed keywords

BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY; RABIES VACCINE; THROMBOSPONDIN; VIRUS VECTOR;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CAT; CONTROLLED STUDY; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG SAFETY; GENE CONSTRUCT; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; POXVIRUS; PRIORITY JOURNAL; RABIES; RACCOON; STATISTICAL ANALYSIS; VIRUS ISOLATION; VIRUS SHEDDING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, VIRAL; CAT DISEASES; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPROTEINS; LAC OPERON; MUCOUS MEMBRANE; NEUTRALIZATION TESTS; ORTHOPOXVIRUS; RACCOONS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS DISEASES;

EID: 1942507454     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860410001670062     Document Type: Article

References (36)

1. Beaud, G. (1995) "Vaccinia virus DNA replication: a short review", Biochimie 77, 774-779.
2. Buller, R.M., Smith, G.L., Cremer, K., Notkins, A.L. and Moss, B. (1985) "Decreased virulence of recombinant vaccine virus expression vectors is associated with a thymidine kinase-negative phenotype", Nature 317, 813-815.
3. Carroll, M.W. and Moss, B. (1997) "Poxviruses as expression vectors", Curr. Opin. Biotechnol. 8, 573-577.
4. Cocker, F.M., Gaskell, R.M., Newby, T.J., Gaskell, C.J., Stokes, C.R. and Bourne, F.J. (1984) "Efficacy of early (48 and 96 hour) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant", Vet. Rec. 114, 353-354.
5. Cocker, F.M., Newby, T.J., Gaskell, R.M., Evans, P.A., Gaskell, C.J., Stokes, C.R., Harbour, D.A. and Bourne, J.F. (1986) "Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1", Res. Vet. Sci. 41, 323-330.
6. DeMartini, J.C., Bickle, H.M., Brodie, S.J., He, B.X. and Esposito, J.J. (1993) "Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep", Arch. Virol., 133.
7. Ellner, P.D. (1998) "Smallpox: gone but not forgotten", Infection 26, 263-269.
8. Esplin, D.G., McGill, L.D., Meininger, A.C. and Wilson, S.R. (1993) "Postvaccination sarcomas in cats", J. Am. Vet. Med. Assoc. 202, 1245-1247.
9. Esposito, J.J., Knight, J.C., Shaddock, J.H., November, F.J. and Baer, G.M. (1988) "Successful oral rabies vaccination of raccoons with raccoon poxviurs recombinants expressing rabies virus glycoprotein", Virology 165, 313-316.
10. Esposito, J.J., Chandler, F.W. and Baer, G.M. (1989) "Oral immunization of animals with raccoon poxvirus expressing rabies virus glycoprotein", Vaccines 89 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), pp 403-408.
11. Fekadu, M., Shaddock, J.H., Sumner, J.W., Sanderlin, D.W., Knight, J.C., Esposito, J.J. and Baer, G.M. (1991) "Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein", J. Wildl. Dis. 27, 681-684.
12. Fenner, F. (1979) "Portraits of viruses: the poxviruses", Intervirology 11, 137-157.
13. Flexner, C. and Moss, B. (1997) "New generation vaccines", In: Levine, M.M., Woodrow, G.C., Kasper, J.B. and Cobon, G.S., eds, New Generation Vaccines (Marcel Dekker, New York), pp 297-314.
14. Girard, M., Habel, A. and Chanel, C. (1999) "New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview", C R Acad. Sci. III 322, 959-966.
15. Hekker, A.C., Bos, J.M. and Smith, L. (1973) "A stable freeze-dried smallpox vaccine made in monolayer cultures of primary rabbit kidney cells", J. Biol. Stand. 1, 21-32.
16. Hendrick, M.J., Kass, P.H., McGill, L.D. and Tizard, I.R. (1994) "Postvaccinal sarcomas in cats", J. Natl Cancer Inst. 86, 341-343.
17. Herman, Y.F. (1964) "Isolation and characterization of a naturally occurring poxvirus of raccoons", Bacteriol. Proc. 64th Annu. Meeting Am. Soc. Microbiol., 117.
18. Hou, Y., Hu, W.G., Hirano, T. and Gu, X.X. (2002) "A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model", Vaccine 20, 2375-2381.
19. Hu, L., Esposito, J.J. and Scott, F.W. (1996) "Raccoon poxvirus feline panleukopenia virus FP2 recombinant protects cats against FPV challenge", Virology 218, 248-252.
20. Hu, L., Ngichabe, C., Trimarchi, C.V., Esposito, J.J. and Scott, F.W. (1997) "Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine", Virology 15, 1466-1472.
21. Kunisawa, J., Sakaue, G. and Kiyono, H. (2000) "NALT immune system for the development of AIDS mucosal vaccine", Nihon Rinsho Meneki Gakkai Kaishi 23, 579-581.
22. Lofquist, J.M., Weimert, N.A. and Hayney, M.S. (2003) "Smallpox: a review of clinical disease and vaccination", Am. J. Health Syst. Pharm. 60, 749-756, quiz 757-748.
23. Mackett, M., Smith, G.L. and Moss, B. (1992) "Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982", Biotechnology 24, 495-499.
24. Nakano, J.H. and Esposito, J.J. (1989) "Poxviruses", In: Scmidt, N.J. and Emmons, R.W., eds, Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections (American Public Health Association, Washington, DC), p 224.
25. Niemialtowski, M.G., Toka, F.N., Malicka, E., Gierynska M., Spohr de Faundez, I. and Schollenberger, A. (1996) "Controlling orthopoxvirus infections - 200 years after Jenner's revolutionary immunization", Arch. Immunol. Ther. Exp. (Warsz) 44, 373-378.
26. Osorio, J.E., Powell, T.D., Frank, R.S., Moss, K., Haanes, E.J., Smith, S.R., Rocke, T.E. and Stinchcomb, D.T. (2003) " Recombinant raccoon pox vaccine protects mice against lethal plague" , Vaccine 21, 1232-1238.
27. Paoletti, E. (1996) "Applications of pox virus vectors to vaccination: an update", Proc. Natl Acad. Sci. USA 93, 11349-11353.
28. Pincus, S., Tartaglia, J. and Paoletti, E. (1995) "Poxvirus-based vectors as vaccine candidates", Biologicals 23, 159-164.
29. Rosner, B. (1995) Fundamentals of Biostatistics, 4th Ed. (Duxbury Press, Behimont, CA).
30. Smith, J.S., Yager, P.A. and Baer, G.M. (1996) "A rapid fluorescent focus inhibition test (RIFFT) for determining rabies virus-neutralizing antibody", In: Meslin, F., Kaplan, M.M. and Koprowski, H., eds, Laboratory Techniques in Rabies (World Health Organization, Geneva), pp 181-189.
31. Taylor, J. and Paoletti, E. (1988) "Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines", Prog. Vet. Microbiol. Immunol. 4, 197-217.
32. Velge-Roussel, F., Marcelo, P., Lepage, A.C., Buzoni-Gatel, D. and Bout, D.T. (2000) "Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments", Infect. Immun. 68, 969-972.
33. Wasmoen, T.L., Kadakia, N.P., Unfer, R.C., Fickbohm, B.L., Cook, C.P., Chu, H.J. and Acree, W.M. (1995) "Protection of cats from infectious peritonitis by vacciniation with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus", Adv. Exp. Med. Biol. 380, 221-228.
34. Weiss, D.J., Liggitt, D. and Clark, J.G. (1997) "In situ histochemical detection of beta-galactosidase activity in lung: assessment of X-Gal reagent in distinguishing lacZ gene expression and endogenous beta-galactosidase activity", Hum. Gene. Ther. 8, 1545-1554.
35. Wu, H.Y. and Russell, M.W. (1997) "Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system", Immunnol. Res. 16, 187-201.
36. Yanagita, M., Hiroi, T., Kitagaki, N., Hamada, S., Ito, H.O., Shimauchi, H., Murakami, S., Okada, H. and Kiyono, H. (1999) "Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production", J. Immunol. 162, 3559-3565.